About this Journal Submit a Manuscript Table of Contents
Gastroenterology Research and Practice
Volume 2013 (2013), Article ID 425840, 8 pages
http://dx.doi.org/10.1155/2013/425840
Review Article

Is Helicobacter pylori Infection the Primary Cause of Duodenal Ulceration or a Secondary Factor? A Review of the Evidence

1Department of General and Gastrointestinal Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry 605006, India
2Mahatma Gandhi Medical College & Research Institute, Pondicherry 607402, India
3Division of Surgery and Interventional Science, University College London, London W1W 7ET, UK

Received 27 January 2013; Accepted 7 March 2013

Academic Editor: N. K. Maroju

Copyright © 2013 Vikram Kate et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. L. Langenberg, G. N. J. Tytgat, M. E. I. Schipper, P. J. E. M. Rietra, and H. C. Zanen, “Campylobacter-like organisms in the stomach of patients and healthy individuals,” The Lancet, vol. 1, no. 8390, p. 1348, 1984.
  2. B. E. Dunn, “Pathogenic mechanisms of Helicobacter pylori,” Gastroenterology Clinics of North America, vol. 22, no. 1, pp. 43–56, 1993. View at Scopus
  3. S. M. Kelly, J. R. Crampton, and J. O. Hunter, “Helicobacter pylori increases gastric antral juxtamucosal pH,” Digestive Diseases and Sciences, vol. 38, no. 1, pp. 129–131, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. J. K. Xu, C. S. Goodwin, M. Cooper, and J. Robinson, “Intracellular vacuolization caused by the urease of Helicobacter pylori,” Journal of Infectious Diseases, vol. 161, no. 6, pp. 1302–1304, 1990. View at Scopus
  5. B. D. Gold, M. Huesca, P. M. Sherman, and C. A. Lingwood, “Helicobacter mustelae and Helicobacter pylori bind to common lipid receptors in vitro,” Infection and Immunity, vol. 61, no. 6, pp. 2632–2638, 1993. View at Scopus
  6. W. Dickey, J. S. Collins, R. G. P. Watson, J. M. Sloan, and K. G. Porter, “Secretor status and Helicobacter pylori infection are independent risk factors for gastroduodenal disease,” Gut, vol. 34, no. 3, pp. 351–353, 1993. View at Scopus
  7. P. M. Goggin, T. C. Northfield, and R. T. Spychal, “Factors affecting gastric mucosal hydrophobicity in man,” Scandinavian Journal of Gastroenterology, vol. 26, supplement 181, pp. 65–73, 1991. View at Scopus
  8. T. G. Blanchard, M. L. Drakes, and S. J. Czinn, “Helicobacter infection: pathogenesis,” Current Opinion in Gastroenterology, vol. 20, no. 1, pp. 10–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. K. R. Tummuru, T. L. Cover, and M. J. Blaser, “Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production,” Infection and Immunity, vol. 61, no. 5, pp. 1799–1809, 1993. View at Scopus
  10. N. R. Hussein, “The association of dupA and Helicobacter pylori-related gastroduodenal diseases,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 29, no. 7, pp. 817–821, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Alam, S. Maiti, P. Ghosh, R. De, A. Chowdhury, S. Das, et al., “Significant association of the dupA gene of Helicobacter pylori with duodenal ulcer development in a South-East Indian population,” Journal of Medical Microbiology, vol. 61, pp. 1295–1302, 2012. View at Publisher · View at Google Scholar
  12. S. Levi, K. Beardshall, G. Haddad, R. Playford, P. Ghosh, and J. Calam, “Campylobacter pylori and duodenal ulcers: the gastrin link,” The Lancet, vol. 1, no. 8648, pp. 1167–1168, 1989. View at Scopus
  13. E. J. Prewett, J. T. L. Smith, C. U. Nwokolo, M. Hudson, A. M. Sawyerr, and R. E. Pounder, “Eradication of Helicobacter pylori abolishes 24-hour hypergastrinaemia: a prospective study in healthy subjects,” Alimentary Pharmacology and Therapeutics, vol. 5, no. 3, pp. 283–290, 1991. View at Scopus
  14. D. A. Peura, “Ulcerogenesis: integrating the roles of Helicobacter pylori and acid secretion in duodenal ulcer,” American Journal of Gastroenterology, vol. 92, no. 4, supplement, pp. 8S–16S, 1997. View at Scopus
  15. A. Pietroiusti, I. Luzzi, M. J. Gomez et al., “Helicobacter pylori duodenal colonization is a strong risk factor for the development of duodenal ulcer,” Alimentary Pharmacology and Therapeutics, vol. 21, no. 7, pp. 909–915, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. G. N. J. Tytgat, L. A. Noach, and E. A. J. Rauws, “Helicobacter pylori infection and duodenal ulcer disease,” Gastroenterology Clinics of North America, vol. 22, no. 1, pp. 127–139, 1993. View at Scopus
  17. S. Prasad, M. Mathan, G. Chandy et al., “Prevalence of Helicobacter pylori in Southern Indian controls and patients with gastroduodenal disease,” Journal of Gastroenterology and Hepatology, vol. 9, no. 5, pp. 501–506, 1994. View at Scopus
  18. K. L. Goh, “Prevalence of and risk factors for Helicobacter pylori infection in a multiracial dyspeptic Malaysian population undergoing endoscopy,” Journal of Gastroenterology and Hepatology, vol. 12, no. 6, pp. S29–S35, 1997. View at Scopus
  19. V. Kate, N. Ananthakrishnan, S. Badrinath, and C. Ratnakar, “Prevalence of Helicobacter pylori infection in disorders of the upper gastrointestinal tract in South India,” National Medical Journal of India, vol. 11, no. 1, pp. 5–8, 1998. View at Scopus
  20. D. Y. Graham, G. M. Lew, D. G. Evans, D. J. Evans Jr., and P. D. Klein, “Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing: a randomized controlled trial,” Annals of Internal Medicine, vol. 115, no. 4, pp. 266–269, 1991. View at Scopus
  21. B. J. Marshall, C. S. Goodwin, J. R. Warren et al., “Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori,” The Lancet, vol. 2, no. 8626-8627, pp. 1437–1442, 1988. View at Scopus
  22. P. Malfertheiner, F. Megraud, C. O'Morain et al., “Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report,” Gut, vol. 56, no. 6, pp. 772–781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. L. Schubert and D. A. Peura, “Control of gastric acid secretion in health and disease,” Gastroenterology, vol. 134, no. 7, pp. 1842–1860, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. K. M. Fock, P. Katelaris, K. Sugano et al., “Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection,” Journal of Gastroenterology and Hepatology, vol. 24, no. 10, pp. 1587–1600, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. W. Leong, “Differences in peptic ulcer between the East and the West,” Gastroenterology Clinics of North America, vol. 38, no. 2, pp. 363–379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Shmuely, M. Katicic, T. F. Kanizaj, and Y. Niv, “Helicobacter pylori and nonmalignant diseases,” Helicobacter, vol. 17, supplement 1, pp. 22–25, 2012. View at Publisher · View at Google Scholar
  27. R. Fiocca, E. Solcia, and B. Santoro, “Duodenal ulcer relapse after eradication of Helicobacter pylori,” The Lancet, vol. 337, no. 8757, p. 1614, 1991. View at Publisher · View at Google Scholar · View at Scopus
  28. G. A. Mannes, E. Bayerdorffer, W. Hochter et al., “Decreased relapse rate after antibacterial treatment of Helicobacter pylori associated duodenal ulcers. Munich duodenal ulcer trial,” European Journal of Gastroenterology and Hepatology, vol. 5, no. 3, pp. 145–153, 1993. View at Scopus
  29. A. Ford, B. Delaney, D. Forman, and P. Moayyedi, “Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients,” Cochrane Database of Systematic Reviews, vol. 18, no. 4, p. CD003840, 2004. View at Scopus
  30. J. G. Penston, “Review article. Helicobacter pylori eradication—understandable caution but no excuse for inertia,” Alimentary Pharmacology and Therapeutics, vol. 8, no. 4, pp. 369–389, 1994. View at Scopus
  31. P. Wara, “Incidence, diagnosis, and natural course of upper gastrointestinal hemorrhage. Prognostic value of clinical factors and endoscopy,” Scandinavian Journal of Gastroenterology, vol. 137, pp. 26–27, 1987. View at Scopus
  32. A. Kadayifci and H. Simsek, “Do Helicobacter pylori-positive duodenal ulcers have an increased risk of bleeding?” American Journal of Gastroenterology, vol. 90, no. 10, p. 1901, 1995. View at Scopus
  33. V. Kate, N. Ananthakrishnan, S. Badrinath, S. K. Amarnath, and C. Ratnakar, “Bleeding duodenal ulcer: is Helicobacter pylori a risk factor?” Indian Journal of Gastroenterology, vol. 17, no. 1, pp. 34–35, 1998. View at Scopus
  34. K. C. Lai, W. M. Hui, W. M. Wong et al., “Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage—a long-term randomized, controlled study,” American Journal of Gastroenterology, vol. 95, no. 9, pp. 2225–2232, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Rokkas, A. Karameris, A. Mavrogeorgis, E. Rallis, and N. Giannikos, “Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease,” Gastrointestinal Endoscopy, vol. 41, no. 1, pp. 1–4, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Lubenz and G. Borsch, “Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse,” Digestion, vol. 55, no. 1, pp. 19–23, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. W. A. Stack, J. C. Atherton, G. M. Hawkey, R. F. A. Logan, and C. J. Hawkey, “Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding,” Alimentary Pharmacology and Therapeutics, vol. 16, no. 3, pp. 497–506, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Vergara, F. Casellas, E. Saperas, I. de Torres, J. Lopez, N. Borruel, et al., “Helicobacter pylori eradication prevents recurrence from peptic ulcer hemorrhage,” European Journal of Gastroenterology & Hepatology, vol. 12, no. 7, pp. 733–737, 2000. View at Publisher · View at Google Scholar
  39. J. P. Gisbert, X. Calvet, A. Cosme, P. Almela, F. Feu, F. Bory, et al., “Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding,” The American Journal of Gastroenterology, vol. 107, pp. 1197–1204, 2012. View at Publisher · View at Google Scholar
  40. R. Kochhar and S. Kochhar, “Endoscopic balloon dilation for benign gastric outlet obstruction in adults,” World Journal of Gastrointestinal Endoscopy, vol. 2, no. 1, pp. 29–35, 2010. View at Publisher · View at Google Scholar
  41. S. S. Rana, D. K. Bhasin, V. S. Chandail et al., “Endoscopic balloon dilatation without fluoroscopy for treating gastric outlet obstruction because of benign etiologies,” Surgical Endoscopy, vol. 25, no. 5, pp. 1579–1584, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. H. Lam, J. Y. Lau, T. M. Fung et al., “Endoscopic balloon dilation for benign gastric outlet obstruction with or without Helicobacter pylori infection,” Gastrointestinal Endoscopy, vol. 60, no. 2, pp. 229–233, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Kate, N. Ananthakrishnan, S. Badrinath, S. K. Amarnath, and C. Ratnakar, “Helicobacter pylori infection in duodenal ulcer with gastric outlet obstruction,” Tropical Gastroenterology, vol. 19, no. 2, pp. 75–77, 1998. View at Scopus
  44. J. P. Gisbert and J. M. Pajares, “Review article: Helicobacter pylori infection and gastric outlet obstruction—prevalence of the infection and role of antimicrobial treatment,” Alimentary Pharmacology and Therapeutics, vol. 16, no. 7, pp. 1203–1208, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. A. El-Nakeeb, A. Fikry, T. M. Abd El-Hamed et al., “Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer,” International Journal of Surgery, vol. 7, no. 2, pp. 126–129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. G. J. Valooran, V. Kate, S. Jagdish, and D. Basu, “Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure,” Scandinavian Journal of Gastroenterology, vol. 46, no. 9, pp. 1045–1050, 2011. View at Publisher · View at Google Scholar
  47. P. Tomtitchong, B. Siribumrungwong, R. K. Vilaichone, P. Kasetsuwan, N. Matsukura, and N. Chaiyakunapruk, “Systematic review and meta-analysis: Helicobacter pylori eradication therapy after simple closure of perforated duodenal ulcer,” Helicobacter, vol. 17, no. 2, pp. 148–152, 2012. View at Publisher · View at Google Scholar
  48. G. Yetkin, M. Uludağ, I. Akgün, B. Citgez, and S. Karakoç, “Late results of a simple closure technique and Helicobacter pylori eradication in duodenal ulcer perforation,” Acta Chirurgica Belgica, vol. 110, no. 5, pp. 537–542, 2010.
  49. A. Nuhu, A. G. Madziga, and B. M. Gali, “Acute perforated duodenal ulcer in Maiduguri: experience with simple closure and Helicobacter pylori eradication,” West African Journal of Medicine, vol. 28, no. 6, pp. 384–387, 2009. View at Scopus
  50. D. M. Jensen, S. You, E. Pelayo, and M. E. Jensen, “The prevalence of H. pylori and NSAID use in patients with severe upper gastrointestinal hemorrhage and their potential role in recurrence of ulcer bleeding,” Gastroenterology, vol. 102, p. A90, 1992.
  51. M. Sebastian, V. P. Prem Chandran, Y. I. M. Elashaal, and A. J. Sim, “Helicobacter pylori infection in perforated peptic ulcer disease,” British Journal of Surgery, vol. 82, no. 3, pp. 360–362, 1995. View at Publisher · View at Google Scholar · View at Scopus
  52. E. K. W. Ng, S. C. S. Chung, J. J. Y. Sung et al., “High prevalence of Helicobacter pylori infection in duodenal ulcer perforations not caused by non-steroidal anti-inflammatory drugs,” British Journal of Surgery, vol. 83, no. 12, pp. 1779–1781, 1996. View at Scopus
  53. J. C. Rodríguez-Sanjuán, R. Fernández-Santiago, R. A. García, et al., “Perforated peptic ulcer treated by simple closure and Helicobacter pylori eradication,” World Journal of Surgery, vol. 29, no. 7, pp. 849–852, 2005. View at Publisher · View at Google Scholar
  54. E. K. W. Ng, Y. H. Lam, J. J. Y. Sung et al., “Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial,” Annals of Surgery, vol. 231, no. 2, pp. 153–158, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. V. Kate, N. Ananthakrishnan, and S. Badrinath, “Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies,” British Journal of Surgery, vol. 88, no. 8, pp. 1054–1058, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Metzger, S. Styger, C. Sieber, M. von Flüe, P. Vogelbach, and F. Harder, “Prevalence of Helicobacter pylori infection in peptic ulcer perforations,” Swiss Medical Weekly, vol. 131, no. 7-8, pp. 99–103, 2001. View at Scopus
  57. A. C. Bose, V. Kate, N. Ananthakrishnan, and S. C. Parija, “Helicobacter pylori eradication prevents recurrence after simple closure of perforated duodenal ulcer,” Journal of Gastroenterology and Hepatology, vol. 22, no. 3, pp. 345–348, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Weiner and A. P. Shapiro, “Is Helicobacter pylori really the cause of gastroduodenal disease?” QJM, vol. 91, no. 10, pp. 707–711, 1998. View at Scopus
  59. D. Falush, T. Wirth, B. Linz et al., “Traces of human migrations in Helicobacter pylori populations,” Science, vol. 299, no. 5612, pp. 1582–1585, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. B. Linz, F. Balloux, Y. Moodley et al., “An African origin for the intimate association between humans and Helicobacter pylori,” Nature, vol. 445, no. 7130, pp. 915–918, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Yamaoka, M. S. Osato, A. R. Sepulveda et al., “Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries,” Epidemiology and Infection, vol. 124, no. 1, pp. 91–96, 2000. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Yamaoka, E. Orito, M. Mizokami et al., “Helicobacter pylori in North and South America before Columbus,” FEBS Letters, vol. 517, no. 1–3, pp. 180–184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. J. H. Baron, “Peptic ulcer,” Mount Sinai Journal of Medicine, vol. 67, no. 1, pp. 58–62, 2000. View at Scopus
  64. J. H. Baron and A. Sonnenberg, “Hospital admissions for peptic ulcer and indigestion in London and New York in the 19th and early 20th centuries,” Gut, vol. 50, no. 4, pp. 568–570, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. J. H. Baron and A. Sonnenberg, “Alimentary diseases in the poor and middle class in London 1773–1815, and in New York poor 1797–1818,” Alimentary Pharmacology and Therapeutics, vol. 16, no. 10, pp. 1709–1714, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Kidd and I. M. Modlin, “A century of Helicobacter pylori,” Digestion, vol. 59, no. 1, pp. 1–15, 1998. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Hobsley and F. I. Tovey, “Helicobacter pylori: the primary cause of duodenal ulceration or a secondary infection?” World Journal of Gastroenterology, vol. 7, no. 2, pp. 149–151, 2001. View at Scopus
  68. M. Hobsley, F. I. Tovey, and J. Holton, “Precise role of H. pylori in duodenal ulceration,” World Journal of Gastroenterology, vol. 12, no. 40, pp. 6413–6419, 2006. View at Scopus
  69. M. Hobsley, F. I. Tovey, and J. Holton, “Controversies in the Helicobacter pylori/duodenal ulcer story,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 102, no. 12, pp. 1171–1175, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. F. I. Tovey and M. Hobsley, “Is Helicobacter pylori the primary cause of duodenal ulceration?” Journal of Gastroenterology and Hepatology, vol. 14, no. 11, pp. 1053–1056, 1999. View at Publisher · View at Google Scholar · View at Scopus
  71. I. Segal, R. Ally, F. Sitas, and A. R. P. Walker, “Co-screening for primary biliary cirrhosis and coeliac disease. Helicobacter pylori: the African enigma,” Gut, vol. 43, no. 2, pp. 300–301, 1998. View at Scopus
  72. I. Segal, R. Ally, and H. Mitchell, “Helicobacter pylori—an African perspective,” QJM, vol. 94, no. 10, pp. 561–565, 2001. View at Scopus
  73. F. I. Tovey, M. Hobsley, S. P. Kaushik et al., “Duodenal gastric metaplasia and Helicobacter pylori infection in high and low duodenal ulcer-prevalent areas in India,” Journal of Gastroenterology and Hepatology, vol. 19, no. 5, pp. 497–505, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. C. Holcombe, “Helicobacter pylori: the African enigma,” Gut, vol. 33, no. 4, pp. 429–431, 1992. View at Scopus
  75. F. I. Tovey, M. Hobsley, I. Segal, and A. P. Jayaraj, “Duodenal ulcer in South Africa: home-pounded versus milled maize,” Journal of Gastroenterology and Hepatology, vol. 20, no. 7, pp. 1008–1011, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. F. I. Tovey, “Duodenal ulcer in China,” Journal of Gastroenterology and Hepatology, vol. 7, no. 4, pp. 427–431, 1992. View at Scopus
  77. B. C. Y. Wong, C. K. Ching, S. K. Lam et al., “Differential North to South gastric cancer-duodenal ulcer gradient in China. China Ulcer Study Group,” Journal of Gastroenterology and Hepatology, vol. 13, no. 10, pp. 1050–1057, 1998. View at Scopus
  78. C. K. Ching and S. K. Lam, “Helicobacter pylori epidemiology in relation to peptic ulcer and gastric cancer in South and North China,” Journal of Gastroenterology and Hepatology, vol. 9, supplement 1, pp. S4–S7, 1994. View at Scopus
  79. C. Holcombe, B. A. Omotara, J. Eldridge, and D. M. Jones, “Helicobacter pylori, the most common bacterial infection in Africa. A random serological study,” American Journal of Gastroenterology, vol. 87, no. 1, pp. 28–30, 1992. View at Scopus
  80. C. Holcombe, B. A. Omotara, M. K. O. Padonu, and A. P. Bassi, “The prevalence of symptoms of dyspepsia in north eastern Nigeria. A random community based survey,” Tropical and Geographical Medicine, vol. 43, no. 1-2, pp. 209–214, 1991. View at Scopus
  81. F. I. Tovey and M. Tunstall, “Duodenal ulcer in back populations in Africa South of the Sahara,” Gut, vol. 16, no. 7, pp. 564–576, 1975. View at Scopus
  82. F. I. Tovey, M. Hobsley, and J. Holton, “Helicobacter pylori virulence factors in duodenal ulceration: a primary cause or a secondary infection causing chronicity,” World Journal of Gastroenterology, vol. 12, no. 1, pp. 6–9, 2006. View at Scopus
  83. P. Bytzer and P. S. Teglbjærg, “Helicobacter pylori—negative duodenal ulcers: prevalence, clinical characteristics, and prognosis—results from a randomized trial with 2-year follow-up,” American Journal of Gastroenterology, vol. 96, no. 5, pp. 1409–1416, 2001. View at Publisher · View at Google Scholar · View at Scopus
  84. L. Laine, R. J. Hopkins, and L. S. Girardi, “Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials,” American Journal of Gastroenterology, vol. 93, no. 9, pp. 1409–1415, 1998. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Jyotheeswaran, A. N. Shah, H. O. Jin, G. D. Potter, F. V. Ona, and W. Y. Chey, “Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?” American Journal of Gastroenterology, vol. 93, no. 4, pp. 574–578, 1998. View at Publisher · View at Google Scholar · View at Scopus
  86. T. J. Borody, L. L. George, S. Brandl et al., “Helicobacter pylori-negative duodenal ulcer,” American Journal of Gastroenterology, vol. 86, no. 9, pp. 1154–1157, 1991. View at Scopus
  87. A. A. Ciociola, D. J. McSorley, K. Turner, D. Sykes, and J. B. D. Palmer, “Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated,” American Journal of Gastroenterology, vol. 94, no. 7, pp. 1834–1840, 1999. View at Publisher · View at Google Scholar · View at Scopus
  88. P. Dres Pest, J. Zárate, C. Varsky, F. Man, and M. Schraier, “Helicobacter pylori in recently-diagnosed versus chronic duodenal ulcer,” Acta Gastroenterologica Latinoamericana, vol. 26, no. 5, pp. 273–276, 1996. View at Scopus
  89. P. B. Boulos, A. Botha, M. Hobsley, J. Holton, A. O. Oshowo, and F. I. Tovey, “Possible absence of Helicobacter pylori in the early stages of duodenal ulceration,” QJM, vol. 95, no. 11, pp. 749–752, 2002. View at Scopus
  90. D. H. Reinbach, G. Cruickshank, and K. E. L. McColl, “Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection,” Gut, vol. 34, no. 10, pp. 1344–1347, 1993. View at Scopus
  91. M. Hobsley and P. F. Whitfield, “The likelihood of a disease in relation to the magnitude of a risk factor. The example of duodenal ulcer,” Theoretical Surgery, vol. 2, no. 3, pp. 6–9, 1987. View at Scopus
  92. K. Chandrakumaran, D. Vaira, and M. Hobsley, “Duodenal ulcer, Helicobacter pylori, and gastric secretion,” Gut, vol. 35, no. 8, pp. 1033–1036, 1994. View at Scopus
  93. K. Schwarz, “Ueber penetrierende magen- und jejunal geshwure,” Bruns' Beiträge für Klinische Chirurgie, vol. 67, pp. 96–128, 1910.
  94. F. I. Tovey, A. P. Jayaraj, M. R. Lewin, and C. G. Clark, “Diet: its role in the genesis of peptic ulceration,” Digestive Diseases, vol. 7, no. 6, pp. 309–323, 1989. View at Scopus
  95. F. I. Tovey, “Diet and duodenal ulcer,” Journal of Gastroenterology and Hepatology, vol. 9, no. 2, pp. 177–185, 1994. View at Scopus
  96. A. P. Jayaraj, F. I. Tovey, and C. G. Clark, “Possible dietary protective factors in relation to the distribution of duodenal ulcer in India and Bangladesh,” Gut, vol. 21, no. 12, pp. 1068–1076, 1980. View at Scopus
  97. A. P. Jayaraj, F. I. Tovey, M. R. Lewin, and C. G. Clark, “Duodenal ulcer prevalence: experimental evidence for the possible role of dietary lipids,” Journal of Gastroenterology and Hepatology, vol. 15, no. 6, pp. 610–616, 2000. View at Publisher · View at Google Scholar · View at Scopus
  98. A. P. Jayaraj, F. I. Tovey, and M. Hobsley, “Duodenal ulcer prevalence: research into the nature of possible protective dietary lipids,” Phytotherapy Research, vol. 17, no. 4, pp. 391–398, 2003. View at Publisher · View at Google Scholar · View at Scopus
  99. F. I. Tovey, D. Capanoglu, G. J. Langley, J. M. Herniman, S. Bor, O. Ozutemiz, et al., “Dietary phytosterols protective against peptic ulceration,” Gastroenterology Research, vol. 4, no. 4, pp. 149–156, 2011.
  100. F. I. Tovey, K. D. Bardhan, and M. Hobsley, “Dietary phospholipids and sterols protective against peptic ulceration,” Phytotherapy Research, 2012. View at Publisher · View at Google Scholar
  101. M. Hobsley, F. I. Tovey, and J. Holton, “How labile is gastric infection with H. pylori?” World Journal of Gastroenterology, vol. 13, no. 35, pp. 4665–4667, 2007. View at Scopus
  102. B. J. Marshall, L. J. Barrett, C. Prakash, R. W. McCallum, and R. L. Guerrant, “Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid,” Gastroenterology, vol. 99, no. 3, pp. 697–702, 1990. View at Scopus
  103. J. E. Sjöström and H. Larsson, “Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant,” Journal of Medical Microbiology, vol. 44, no. 6, pp. 425–433, 1996. View at Scopus
  104. M. Clyne, A. Labigne, and B. Drumm, “Helicobacter pylori requires an acidic environment to survive in the presence of urea,” Infection and Immunity, vol. 63, no. 5, pp. 1669–1673, 1995. View at Scopus
  105. B. J. Marshall, J. A. Armstrong, D. B. McGechie, and R. J. Glancy, “Attempt to fulfil Koch's postulates for pyloric campylobacter,” Medical Journal of Australia, vol. 142, no. 8, pp. 436–439, 1985. View at Scopus
  106. H. R. Pearce, N. Kalia, K. D. Bardhan, J. C. Atherton, and N. J. Brown, “Effects of Helicobacter pylori on endothelial cell proliferation and chemotaxis,” Digestion, vol. 69, no. 4, pp. 201–210, 2004. View at Publisher · View at Google Scholar · View at Scopus
  107. G. Tabel, N. T. Hoa, A. Tarnawski, J. Chen, M. Domek, and T. Y. Ma, “Helicobocter pylori infection inhibits healing of the wounded duodenal epithelium in vitro,” Journal of Laboratory and Clinical Medicine, vol. 142, no. 6, pp. 421–430, 2003. View at Publisher · View at Google Scholar · View at Scopus